Exploring miRNA Profiles in Colon Cancer: A Focus on miR101-3p, miR106a-5p, and miR326

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Early diagnosis and prognosis are critical for effective colon cancer patient management.
• Biomarker profiling, particularly microRNA (miRNA) expression, offers a promising avenue for improving colon cancer detection and outcome prediction.

Purpose of the Study:

• To investigate the expression levels of miR-101-3p, miR-106a-5p, and miR-326 in colon cancer tissues and adjacent healthy tissues.
• To evaluate the diagnostic and prognostic utility of these miRNAs in colon cancer progression.

Main Methods:

• Analysis of miRNA expression using quantitative reverse transcription polymerase chain reaction (qRT-PCR).
• Inclusion of 40 colon cancer patients stratified into four groups based on TNM staging.

Main Results:

• A significant decrease in miR-101-3p, miR-106a-5p, and miR-326 expression was observed in tumor tissues compared to adjacent healthy tissues, particularly in advanced cancer stages.
• MiR-106a-5p and miR-326 demonstrated a strong correlation with the severity of colon cancer.
• Overexpression of these miRNAs was noted in healthy tissues, with a decline correlating to tumor progression.

Conclusions:

• MiRNA profiling, specifically analyzing miR-101-3p, miR-106a-5p, and miR-326, holds potential as a valuable tool for the early diagnosis of colon cancer.
• These miRNAs may serve as prognostic biomarkers, aiding in the management and treatment strategies for colon cancer patients.